Novel miRNA biomarker and treatment of memory impairment

Age associated dementia consist a serious health and social problem for our society, with their prevalence increasing as lifespan expands. Efficient therapeutic strategies to treat memory decline are still missing. Scientists of the University of Göttingen have now developed a new biomarker and medical approach for treatment of dementia and of other memory impairment conditions. This includes discovery of a new microRNA (miRNA) biomarker associated with learning and memory and its therapeutic manipulation, in particular to rescue learning impairment in dementia.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

NASA: Mystery of life’s handedness deepens

The mystery of why life uses molecules with specific orientations has deepened with a NASA-funded discovery that RNA — a key molecule thought to have potentially held the instructions for…

What are the effects of historic lithium mining on water quality?

Study reveals low levels of common contaminants but high levels of other elements in waters associated with an abandoned lithium mine. Lithium ore and mining waste from a historic lithium…

Quantum-inspired design boosts efficiency of heat-to-electricity conversion

Rice engineers take unconventional route to improving thermophotovoltaic systems. Researchers at Rice University have found a new way to improve a key element of thermophotovoltaic (TPV) systems, which convert heat…